A detailed history of Sarissa Capital Management LP transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Sarissa Capital Management LP holds 618,000 shares of VOR stock, worth $488,220. This represents 0.11% of its overall portfolio holdings.

Number of Shares
618,000
Previous 618,000 -0.0%
Holding current value
$488,220
Previous $618,000 30.1%
% of portfolio
0.11%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.89 - $6.44 $346,248 - $573,224
-89,010 Reduced 12.59%
618,000 $3.07 Million
Q1 2021

May 17, 2021

BUY
$30.96 - $54.08 $21.9 Million - $38.2 Million
707,010 New
707,010 $30.5 Million

Others Institutions Holding VOR

About Vor Biopharma Inc.


  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $30.1M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Sarissa Capital Management LP Portfolio

Follow Sarissa Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarissa Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sarissa Capital Management LP with notifications on news.